Endoscope Service – Market Insights – United States

The US endoscope service market will experience slow growth over the forecast period. The increasing need for endoscope servicing is driven by escalating demand for endoscopes, especially during MIS and in ASC procedures. Screening guidelines and the increasing prevalence of chronic diseases also contribute to the extensive use of endoscopes, driving demand for their repair and maintenance. OEMs will generate the largest share of revenue because they can offer proprietary parts and expert servicing capabilities to healthcare facilities; meanwhile, third-party companies offering cost-effective, convenient, and multibrand solutions will drive revenues in cost-constrained healthcare facilities. However, market growth will be hindered by concerns of infection and cross-contamination, which contribute to the increasing adoption of disposable endoscopes.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for endoscope service in the US from 2019 through 2034.

OEMs will be leading the US endoscope service market over the forecast period, driven by their service offerings.

Which OEMs are leading the US endoscope service market, and what specific services do they provide?

What strategies and initiatives help OEMs grow their endoscope service revenues?

How will the current position of OEMs in endoscope device segments impact their position in the endoscope service market?

There is a difference in the services provided by OEMs and third-party companies.

How does growth differ between OEMs and third-party companies in the endoscope service market?

What are the key factors that help healthcare facilities choose between third-party companies and OEMs for endoscope servicing?

What are the common challenges faced by third-party endoscope service providers in gaining market share from OEMs?

The increased use of disposable endoscopes, as recommended by the FDA, is expected to impact revenues in the endoscope service market.

What measures has the FDA implemented in response to contamination concerns associated with reprocessed scopes?

How do FDA guidelines encourage healthcare facilities to shift toward disposable endoscopes?

What impact will these guidelines have on OEMs and third-party service providers?